Pages that link to "Item:Q3079146"

The following pages link to Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials (Q3079146):

Displaying 44 items.

• Sensitivity analysis for stratified comparisons in an observational study of the effect of smoking on homocysteine levels (Q101946) (← links)
• Chop-Lump Tests for Vaccine Trials (Q109179) (← links)
• Nonparametric bounds and sensitivity analysis of treatment effects (Q252812) (← links)
• Interference and sensitivity analysis (Q252826) (← links)
• Defining and estimating intervention effects for groups that will develop an auxiliary outcome (Q449753) (← links)
• On the estimation of a binary response model in a selected population (Q550118) (← links)
• The potential for bias in principal causal effect estimation when treatment received depends on a key covariate (Q652349) (← links)
• Assessment of the extent of corroboration of an elaborate theory of a causal hypothesis using partial conjunctions of evidence factors (Q1996769) (← links)
• Sensitivity analysis for evaluating principal surrogate endpoints relaxing the equal early clinical risk assumption (Q2170431) (← links)
• An exact adaptive test with superior design sensitivity in an observational study of treatments for ovarian cancer (Q2428737) (← links)
• Assessing surrogate endpoints in vaccine trials with case-cohort sampling and the Cox model (Q2482986) (← links)
• Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials (Q3079146) (← links)
• Sensitivity Analyses Comparing Time-to-Event Outcomes Only Existing in a Subset Selected Postrandomization and Relaxing Monotonicity (Q3100820) (← links)
• Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data (Q3303582) (← links)
• A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infections (Q3304977) (← links)
• Incorporating founder virus information in vaccine field trials (Q3459936) (← links)
• Sensitivity Analysis for Principal Stratum Direct Effects, with an Application to a Study of Physical Activity and Coronary Heart Disease (Q3636999) (← links)
• Assessing Treatment‐Selection Markers using a Potential Outcomes Framework (Q4649041) (← links)
• Partially Hidden Markov Model for Time-Varying Principal Stratification in HIV Prevention Trials (Q4916438) (← links)
• Impact of Multiple Matched Controls on Design Sensitivity in Observational Studies (Q4919569) (← links)
• Estimation of attributable fractions using inverse probability weighting (Q4924359) (← links)
• Weighted <i>M</i>-statistics With Superior Design Sensitivity in Matched Observational Studies With Multiple Controls (Q4975566) (← links)
• Optimal Tradeoffs in Matched Designs Comparing US-Trained and Internationally Trained Surgeons (Q5146018) (← links)
• The Blessings of Multiple Causes (Q5208062) (← links)
• Augmented Designs to Assess Immune Response in Vaccine Trials (Q5295377) (← links)
• Sharpening Bounds on Principal Effects with Covariates (Q5407995) (← links)
• Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis (Q5424960) (← links)
• Designs in partially controlled studies: messages from a review (Q5424965) (← links)
• What can Statistics Contribute to a Causal Understanding? (Q5430605) (← links)
• Rejoinder (Q5434890) (← links)
• Simple maximum likelihood estimates of efficacy in randomized trials and before-and-after studies, with implications for meta-analysis (Q5442624) (← links)
• Designs in partially controlled studies: messages from a review (Q5442627) (← links)
• Sensitivity Analyses Comparing Outcomes Only Existing in a Subset Selected Post‐Randomization, Conditional on Covariates, with Application to HIV Vaccine Trials (Q5492070) (← links)
• Polydesigns and Causal Inference (Q5492071) (← links)
• A Potential Outcomes Approach to Developmental Toxicity Analyses (Q5492072) (← links)
• Reinforced Designs: Multiple Instruments Plus Control Groups as Evidence Factors in an Observational Study of the Effectiveness of Catholic Schools (Q5857127) (← links)
• The survival-incorporated median vs the median in the survivors or in the always-survivors: what are we measuring? And why? (Q6560550) (← links)
• Estimation of treatment effect among treatment responders with a time-to-event endpoint (Q6608188) (← links)
• Sensitivity analyses for average treatment effects when outcome is censored by death in instrumental variable models (Q6627095) (← links)
• Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design (Q6628355) (← links)
• Survival mediation analysis with the death-truncated mediator: the completeness of the survival mediation parameter (Q6628416) (← links)
• Using principal stratification in analysis of clinical trials (Q6628508) (← links)
• Large sample bounds on the survivor average causal effect in the presence of a binary covariate with conditionally ignorable treatment assignment (Q6632700) (← links)
• Selection bias when using instrumental variable methods to compare two treatments but more than two treatments are available (Q6632732) (← links)